Turakhia Mintu P, Zweibel Steven, Swain Andrea L, Mollenkopf Sarah A, Reynolds Matthew R
From the Center for Digital Health, Stanford University School of Medicine, Stanford, CA (M.P.T.); the Division of Cardiac Electrophysiology, Hartford Healthcare Heart and Vascular Institute, Hartford, CT (S.Z.); the Department of Economics, Reimbursement, and Evidence, Medtronic plc, Mounds View, MN (A.L.S., S.A.M.); and Baim Institute for Clinical Research, Boston, MA (M.R.R.).
Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). doi: 10.1161/CIRCOUTCOMES.115.002210.
In patients with implantable cardioverter-defibrillators, healthcare utilization (HCU) and expenditures related to shocks have not been quantified.
We performed a retrospective cohort study of patients with implantable cardioverter-defibrillators identified from commercial and Medicare supplemental claims databases linked to adjudicated shock events from remote monitoring data. A shock event was defined as ≥1 spontaneous shocks delivered by an implanted device. Shock-related HCU was ascertained from inpatient and outpatient claims within 7 days following a shock event. Shock events were adjudicated and classified as inappropriate or appropriate, and HCU and expenditures, stratified by shock type, were quantified. Of 10 266 linked patients, 963 (9.4%) patients (61.3±13.6 years; 81% male) had 1885 shock events (56% appropriate, 38% inappropriate, and 6% indeterminate). Of these events, 867 (46%) had shock-related HCU (14% inpatient and 32% outpatient). After shocks, inpatient cardiovascular procedures were common, including echocardiography (59%), electrophysiology study or ablation (34%), stress testing (16%), and lead revision (11%). Cardiac catheterization was common (71% and 51%), but percutaneous coronary intervention was low (6.5% and 5.0%) after appropriate and inappropriate shocks. Expenditures related to appropriate and inappropriate shocks were not significantly different.
After implantable cardioverter-defibrillator shock, related HCU was common, with 1 in 3 shock events followed by outpatient HCU and 1 in 7 followed by hospitalization. Use of invasive cardiovascular procedures was substantial, even after inappropriate shocks, which comprised 38% of all shocks. Implantable cardioverter-defibrillator shocks seem to trigger a cascade of health care. Strategies to reduce shocks could result in cost savings.
在植入式心律转复除颤器患者中,与电击相关的医疗服务利用(HCU)和费用尚未得到量化。
我们对从商业和医疗保险补充索赔数据库中识别出的植入式心律转复除颤器患者进行了一项回顾性队列研究,这些数据库与来自远程监测数据的经判定的电击事件相关联。电击事件定义为植入设备发出≥1次自发电击。电击相关的HCU通过电击事件发生后7天内的住院和门诊索赔确定。对电击事件进行判定并分类为不适当或适当,并按电击类型分层量化HCU和费用。在10266名关联患者中,963名(9.4%)患者(61.3±13.6岁;81%为男性)发生了1885次电击事件(56%为适当电击,38%为不适当电击,6%为不确定电击)。在这些事件中,867次(46%)有电击相关的HCU(14%为住院,32%为门诊)。电击后,住院心血管手术很常见,包括超声心动图检查(59%)、电生理检查或消融(34%)、压力测试(16%)和导线修复(11%)。心脏导管插入术很常见(适当电击后为71%,不适当电击后为51%),但适当和不适当电击后经皮冠状动脉介入治疗的比例较低(分别为6.5%和5.0%)。与适当和不适当电击相关的费用没有显著差异。
植入式心律转复除颤器电击后,相关的HCU很常见,三分之一的电击事件后有门诊HCU,七分之一的电击事件后需要住院治疗。即使在占所有电击事件38%的不适当电击后,侵入性心血管手术的使用也很普遍。植入式心律转复除颤器电击似乎会引发一系列医疗保健问题。减少电击的策略可能会节省成本。